SARS-CoV-2 Germany/BavPat1/2020 – CFHI
SARS-Related Coronavirus 2 Lineage B (Isolate: Germany/ BavPat1/2020) is an enveloped, positivesense single-stranded RNA virus from the Coronaviridae family and the Betacoronaviridaegenus. Severe acute respiratory syndrome-related 2 (SARS-CoV-2), isolate coronavirus Germany/BavPat1/2020 (also referred to as Germany/MUC-IMB1/2020 or Human/DEU/BavPat1- ChVir929/2020) was isolated from a sputum sample from a mildly symptomatic adult male patient identified as Patient One in the Bavarian cluster on January 28, 2020 in Bavaria, Germany. Under the nomenclature system introduced by GISAID (Global Initiative on Sharing All Influenza Data), SARS-CoV-2, isolate Germany/BavPat1/2020 is assigned lineage B and GISAID clade G using Phylogenetic Assignment of Named Global Outbreak LINeages (PANGOLIN tool. The complete genome sequence of SARS-CoV-2, isolate Germany/BavPat1/2020 has been sequenced (GenBank: MT270101 and GISAID: EPI_ISL_406862).
Each frozen aliquot contains 1 mL of heat inactivated viral culture fluid. The pre-inactivation titer was determined from an infectious aliquot. Viral inactivation is verified after heat inactivation by the absence of viral growth in tissue culture-based infectivity assays.
Heat inactivated viral culture fluids are sold as consumable testing materials. The suitability and performance characteristics should be determined by your laboratory for each intended usage. These products are NOT intended for use in the manufacture or processing of injectable products subject to licensure under section 351 of the Public Health Service Act or for any other product intended for administration to humans.
For BSL-2 or BSL-3 compliant labs only / -20° C.
|BTN - HC|